Eikon Therapeutics (EIKN) Stock Insights
EIKN$5.68+0.14 +2.43%
$307.51M
Market Cap
—
P/E
—
Forward P/E
—
Score
Eikon Therapeutics (EIKN) Stock Insights
EIKN price $5.68 +0.14 +2.43%
- Ticker
- EIKN
- Price
- $5.68
- Change
- +0.14 +2.43%
- Market cap ?
- $307.51M
- Beta ?
- 0.94
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
EIKN fair value Not meaningful. Price $5.68.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -1.74 | — | — |
| 2026-08-13 | -1.63 | -1.58 | — | — |
| 2026-05-11 | -2.46 | -1.47 | — | — |
| 2026-03-30 | -27.00 | -3.56 | — | — |
| 2025-12-03 | -11.50 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Column Group IV GP, LP | Buy | 89.20K | $11.56 | 1.03M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 78, holders +26 vs prior quarter. Ownership 49.26%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FMR LLC | 4.99M | 1.16M | +30.16% | 65.17M |
| BLACKROCK, INC. | 4.28M | 962.05K | +28.98% | 55.87M |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 1.94M | 0 | 0.00% | 25.37M |
| MERCK & CO., INC. | 1.67M | 0 | 0.00% | 21.75M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.60M | 372.79K | +30.49% | 20.82M |
| FORESITE CAPITAL MANAGEMENT V, LLC | 1.32M | 0 | 0.00% | 17.21M |
| CAPITAL WORLD INVESTORS | 1.18M | 32.31K | +2.82% | 15.35M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.01M | 29.20K | +2.99% | 13.12M |
| VANGUARD CAPITAL MANAGEMENT LLC | 922.71K | -46.72K | -4.82% | 12.04M |
| ECOR1 CAPITAL, LLC | 732.61K | 0 | 0.00% | 9.56M |
| GEODE CAPITAL MANAGEMENT, LLC | 556.96K | 283.02K | +103.32% | 7.27M |
| BAKER BROS. ADVISORS LP | 555.55K | 0 | 0.00% | 7.25M |
| ALLIANCEBERNSTEIN L.P. | 641.89K | -380.30K | -37.20% | 6.79M |
| SOROS CAPITAL MANAGEMENT LLC | 484.67K | 0 | 0.00% | 6.32M |
| STEPSTONE GROUP LP | 395.34K | 0 | 0.00% | 5.16M |
| CANADA PENSION PLAN INVESTMENT BOARD | 379.02K | 0 | 0.00% | 4.95M |
| STATE STREET CORP | 354.09K | 313.94K | +781.93% | 4.62M |
| FRANKLIN TEMPLETON INC | 350.00K | 0 | 0.00% | 4.57M |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 305.23K | 0 | 0.00% | 3.98M |
| UBS GROUP AG | 263.93K | 164.52K | +165.50% | 3.44M |
| PARKMAN HEALTHCARE PARTNERS LLC | 256.05K | 256.05K | New | 3.34M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 182.10K | 182.10K | New | 2.38M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 182.10K | 51.03K | +38.93% | 2.38M |
| SCHONFELD STRATEGIC ADVISORS LLC | 179.78K | 179.78K | New | 2.35M |
| NORTHERN TRUST CORP | 175.93K | 130.40K | +286.39% | 2.30M |
Insights · Dividends · Forecast · Financials · Learn